LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析

◆英語タイトル:LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME2467990FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

LivaNova PLC (LIVN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for autotransfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, Greater London, the UK.

LivaNova PLC Key Recent Developments

Apr 28,2021: LivaNova Reports First Quarter 2021 Results
Mar 25,2021: LivaNova to Host Conference Call for First Quarter 2021 Results
Feb 24,2021: LivaNova reports fourth quarter and full-year 2020 results
Jan 05,2021: Medistim partners with LivaNova as their new distributor for India
Dec 07,2020: LivaNova announces board appointment and board leadership changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
LivaNova PLC – Key Facts
LivaNova PLC – Key Employees
LivaNova PLC – Key Employee Biographies
LivaNova PLC – Major Products and Services
LivaNova PLC – History
LivaNova PLC – Company Statement
LivaNova PLC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
LivaNova PLC – Business Description
Business Segment: Cardiovascular
Overview
Performance
Business Segment: Neuromodulation
Overview
Performance
Business Segment: Other
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
LivaNova PLC – Corporate Strategy
LivaNova PLC – SWOT Analysis
SWOT Analysis – Overview
LivaNova PLC – Strengths
LivaNova PLC – Weaknesses
LivaNova PLC – Opportunities
LivaNova PLC – Threats
LivaNova PLC – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
LivaNova PLC, Medical Equipment, Deals By Year, 2015 to YTD 2021
LivaNova PLC, Medical Equipment, Deals By Type, 2015 to YTD 2021
LivaNova PLC, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 28, 2021: LivaNova Reports First Quarter 2021 Results
Mar 25, 2021: LivaNova to Host Conference Call for First Quarter 2021 Results
Feb 24, 2021: LivaNova reports fourth quarter and full-year 2020 results
Jan 05, 2021: Medistim partners with LivaNova as their new distributor for India
Dec 07, 2020: LivaNova announces board appointment and board leadership changes
Dec 04, 2020: LivaNova to host satellite symposium on advances in Neuromodulation at American Epilepsy Society AES2020 virtual event
Oct 29, 2020: LivaNova reports third quarter 2020 results
Jul 29, 2020: LivaNova reports second quarter 2020 results
Jun 29, 2020: LivaNova to Host Conference Call for Second Quarter 2020 Results
Apr 29, 2020: LivaNova reports first quarter 2020 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
LivaNova PLC, Key Facts
LivaNova PLC, Key Employees
LivaNova PLC, Key Employee Biographies
LivaNova PLC, Major Products and Services
LivaNova PLC, History
LivaNova PLC, Subsidiaries
LivaNova PLC, Key Competitors
LivaNova PLC, Ratios based on current share price
LivaNova PLC, Annual Ratios
LivaNova PLC, Annual Ratios (Cont...1)
LivaNova PLC, Annual Ratios (Cont...2)
LivaNova PLC, Interim Ratios
LivaNova PLC, Medical Equipment, Deals By Year, 2015 to YTD 2021
LivaNova PLC, Medical Equipment, Deals By Type, 2015 to YTD 2021
LivaNova PLC, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Earle M. Jorgensen Company:企業の戦略・SWOT・財務分析
    Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report Summary Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • MedImmune LLC-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibo …
  • Edison International (EIX):企業の財務・戦略的SWOT分析
    Edison International (EIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Surgical Innovations Group Plc (SUN):医療機器:M&Aディール及び事業提携情報
    Summary Surgical Innovations Group plc (Surgical Innovations) designs, develops, manufactures and markets medical devices for use in minimally invasive surgery (MIS) and industrial markets. The company offers SI branded products and products for selected original equipment manufacturer (OEM) partner …
  • Nichols plc:戦略・SWOT・企業財務分析
    Nichols plc - Strategy, SWOT and Corporate Finance Report Summary Nichols plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • University of British Columbia-製薬・医療分野:企業M&A・提携分析
    Summary University of British Columbia (UBC) is a research institute that offers educational services. The university provides undergraduate, graduate educational programs, and research programs through its schools and faculties. It provides cultural, recreational and social activities for its stude …
  • Apexigen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Apexigen Inc (Apexigen) is a clinical-stage biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of cancer. The company’s lead immune oncology program APX005M, is a humanized monoclonal antibody that stimulates cancer specific T-cell responses. It also …
  • Reyes Holdings, L.L.C.:企業の戦略・SWOT・財務分析
    Reyes Holdings, L.L.C. - Strategy, SWOT and Corporate Finance Report Summary Reyes Holdings, L.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • China Railway Group Ltd:企業の戦略・SWOT・財務情報
    China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Asahi Kasei Corp (3407)-エネルギー分野:企業M&A・提携分析
    Summary Asahi Kasei Corp (Asahi Kasei), formerly Asahi Chemical Industry Co. Ltd., manufactures, processes, and sells chemical products. It is a holding company of Asahi Kasei Group. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation …
  • LIC of India:企業の戦略・SWOT・財務分析
    LIC of India - Strategy, SWOT and Corporate Finance Report Summary LIC of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • KS Energy Ltd (578):企業の財務・戦略的SWOT分析
    KS Energy Ltd (578) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Turisthotel d.d.:企業の戦略・SWOT・財務情報
    Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report Summary Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Amgen, Inc.:企業のM&A・事業提携・投資動向
    Amgen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amgen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • BW Offshore Ltd (BWO):石油・ガス:M&Aディール及び事業提携情報
    Summary BW Offshore Ltd (BW Offshore) is a floating production services provider to the oil and gas industry. The company specializes in the design, development, and operation of oil and gas Floating Production, Storage and Offloading (FPSO) and Floating, Storage and Offloading (FSO) vessels. It off …
  • Applied Medical Resources Corporation:企業の戦略的SWOT分析
    Applied Medical Resources Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Mastek Ltd (MASTEK):企業の財務・戦略的SWOT分析
    Mastek Ltd (MASTEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mustek Limited (MST):企業の財務・戦略的SWOT分析
    Mustek Limited (MST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • EnerDel Inc:企業の戦略的SWOT分析
    EnerDel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆